MINERVA UROLOGICA E NEFROLOGICA, vol.67, no.3, pp.187-196, 2015 (SCI-Expanded)
Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.